Note that some links may require registration or subscription.
Sen. Dianne Feinstein (D) of California is recovering after being briefly hospitalized after a fall in her home. (ABC News)
Maui hospitals were overwhelmed with burn patients and persons suffering from smoke inhalation from wildfires that have killed at least 36 people and destroyed hundreds of buildings. (CNN)
The Federal Trade Commission warned consumers about a scam targeting Medicare in which people are receiving unordered COVID-19 tests — and bills.
The agency asked the public to weigh in on the proposed expansion of its health data privacy rules. (Politico)
The CDC center that oversaw the agency’s COVID-19 response will soon have new leadership in place. (STAT)
Three people were in critical condition after a car crashed into a Phoenix dialysis center. (KPNX 12News)
To further disrupt global drug trafficking, the White House issued sanctions against three Sinaloa cartel fentanyl suppliers in cooperation with Mexico.
The FDA granted full approval to pralsetinib (Gavreto) for adults with metastatic RET fusion-positive non-small cell lung cancer.
Novo Nordisk’s CEO said limits on U.S. supplies of semaglutide (Wegovy) will continue into next year as the company strives to keep up with demand. (Reuters)
The FDA rejected avasopasem manganese for radiotherapy-induced severe oral mucositis in patients with head and neck cancer, Galera said.
A nonprofit maker of naloxone (RiVive) — the over-the-counter spray used to reverse opioid overdose — is giving away 200,000 doses of the product to celebrate its recent market approval. (STAT)
Research linked testicular cancer among military personnel with “forever chemicals.” (KFF Health News)
A study suggested a trend toward “less vigorous standards” for novel drug approvals. (JAMA Network Open)
Phase III trials evaluating remibrutinib met their primary endpoints and showed rapid symptom control in patients with chronic spontaneous urticaria, Novartis said.
Climate change may worsen the spread of West Nile virus. (Washington Post)
While the FDA’s accelerated approval process helps people access life-saving drugs, some patients end up undergoing treatments known to be ineffective. (Nature)
The World Health Organization classified the EG.5 coronavirus strain currently circulating in the U.S. as a “variant of interest.” (Reuters)
Mike Bassett is a staff writer focusing on oncology and hematology. He is based in Massachusetts.
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/washington-watch/washington-watch/105832